<p>The Effects of Racial/Ethnic Minority Status on Sleep, Mood Disturbance, and Depression in People with Fibromyalgia</p>

Abstract

Purpose: Fibromyalgia syndrome (FMS) is a chronic musculoskeletal pain disorder that is characterized by persistent and widespread pain. FMS has been associated with sleep disturbance, mood disorders and depression. Racial/ethnic minorities are less likely to receive a diagnosis of FMS than White individuals. Although mood disorders and depression are prevalent among racial/ethnic minority groups, researchers have not examined whether there are differences between racial/ethnic minorities and White individuals with FMS. Participants and Methods: The participants were 600 people who were 18 years of age or older and who had a physician's diagnosis of FMS, which was confirmed using the 1990 American College of Rheumatology criteria. Most participants were female (95.5%) and White (85.0%). Sleep disturbance was assessed using the Pittsburgh Sleep Quality Index (PSQI), mood disturbance was assessed using the Profile of Mood States (POMS), and depression was assessed via the Center for Epidemiological Studies Depression Scale (CES-D). Results: Racial/ethnic minorities reported significantly greater levels of sleep disturbance, significantly greater levels of mood disturbance, and had significantly greater levels of depression than White participants. However, racial/ethnic minorities had significantly greater reductions in mood disturbance over the one-year period than White participants. Conclusion: Overall, the findings from the present study indicated that racial/ethnic minorities had "worse" physical and psychological outcomes than White participants.

Health, Psychological and Demographic Predictors of Depression in People with Fibromyalgia and Osteoarthritis

“…However, in the FM group, White participants were more depressed than non-White participants. Marr et al [ 28 ] reported similar findings. In their study, they found that racial and ethnic minorities experienced greater depression, mood disturbances, pain, and poorer health than their White counterparts.…”

“…As with other chronic conditions, people with FM and OA often experience psychological difficulties and report higher rates of depression than those in the general population [ 21 , 22 , 23 , 24 , 25 ]. To study depression in people with these illnesses, researchers have investigated various health, psychological and demographic predictors of depression [ 26 , 27 , 28 , 29 , 30 , 31 ].…”

Mood Disturbances Across the Continuum of Care Based on Self-Report and Clinician Rated Measures in the interRAI Suite of Assessment Instruments

“…Mood disturbances, including symptoms associated with anxiety and depression, have been increasing in prevalence in the population ( 1 – 3 ), and this has been exacerbated greatly due to lockdowns, social isolation, economic and health-related concerns during the COVID-19 pandemic ( 4 – 6 ). Problems of mood may be transitory, but they affect persons of all ages, gender, social class, and cultures.…”

Barriers and facilitators for clinical trial participation of underrepresented and non-underrepresented fibromyalgia patients: A cross-sectional internet survey

“…Fibromyalgia is a condition where 90% of enrolled subjects are women [ 12 ] and has a higher prevalence in minority populations [ 13 ]. Moreover, racial/ethnic minorities report significantly greater levels of symptoms [ 14 ]. Fibromyalgia is a debilitating, poorly understood, and complex chronic pain condition [ 15 ], where most patients are highly impacted by the disease, lacking access to healthcare delivery and suffering significant comorbidities, such as functional and psychiatry disorders [ 16 , 17 ].…”